CDC Planning Guidelines for Genetic Testing Labs | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Centers for Disease Control and Prevention is currently developing guidelines for labs that provide biochemical genetic testing (BGT) and newborn screening (NBS) for inherited metabolic disorders, as well as broader guidelines for molecular genetic testing (MGT), a CDC representative told the Secretary's Advisory Committee on Genetics, Health, and Society on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.